DE eng

Search in the Catalogues and Directories

Page: 1 2
Hits 1 – 20 of 26

1
The trans-ancestral genomic architecture of glycemic traits
Chen, J; Spracklen, CN; Marenne, G. - : Nature Research, 2021
BASE
Show details
2
The trans-ancestral genomic architecture of glycemic traits.
BASE
Show details
3
The trans-ancestral genomic architecture of glycemic traits.
In: Nature genetics, vol. 53, no. 6, pp. 840-860 (2021)
BASE
Show details
4
In Other Words: What’s Happened to Metaphors in the Translation of Political Texts.
Liu, Y.; Wang, C.. - : IGI Global, 2021
BASE
Show details
5
In Other Words: What’s Happened to Metaphors in the Translation of Political Texts
Liu, Y.; Wang, C.. - : IGI Global, 2021
BASE
Show details
6
A semantic collaboration method based on uniform knowledge graph
Li, Q; Cao, Z; Tanveer, M. - : Institute of Electrical and Electronics Engineers, 2019
BASE
Show details
7
Facial feature discovery for ethnicity recognition
BASE
Show details
8
Understanding students' experiences in a PE, health and well-being context : a self-determination theory perspective
BASE
Show details
9
Multi-ethnic facial features extraction based on axiomatic fuzzy set theory
Li, Z.; Duan, X.; Zhang, Q.. - : Elsevier BV, 2017
BASE
Show details
10
The Role of Multi-Media in Expanding Pre-Service Teachers' Understanding of Culturally and Linguistically Diverse Classrooms and Furthering Their Professional Identitie.
In: Handbook of Research on Foreign Language Education in the Digital Age ; https://hal.archives-ouvertes.fr/hal-03129583 ; Handbook of Research on Foreign Language Education in the Digital Age, IGI Global, pp.296-314, 2017 (2017)
BASE
Show details
11
Search for dark matter produced in association with heavy-flavor quark pairs in proton-proton collisions at [Formula: see text]
Sirunyan, A. M.; Tumasyan, A.; Adam, W.. - : Springer Berlin Heidelberg, 2017
BASE
Show details
12
Interpreters = Cultural Mediators?
Wang, C.. - : Department of Translation at the Institute of English, University of Wrocław and the Translatio Doctoral Students' Association, 2017
BASE
Show details
13
Robust and flexible landmarks detection for uncontrolled frontal faces in the wild
Liang, A.; Wang, C.; Liu, Wan-Quan. - : American Institute of Mathematical Sciences, 2016
BASE
Show details
14
Can ethno-linguistic diversity explain cross-country differences in social capital?: A global perspective
Wang, C; Steiner, B. - : Economic Soc Of Australia Brown Prior Anderson Pty Ltd, 2015
BASE
Show details
15
Measurement of the muon reconstruction performance of the ATLAS detector using 2011 and 2012 LHC proton-proton collision data.
In: Symplectic Elements at Oxford ; Europe PubMed Central ; PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2014)
BASE
Show details
16
Radially Composite Ultrasonic Transducers of Piezoelectric Ceramic and Metal Circular Rings
In: Acta acustica united with Acustica. - Stuttgart : Hirzel 98 (2012) 4, 555-566
OLC Linguistik
Show details
17
Basal insulin and cardiovascular and other outcomes in dysglycemia.
In: New England Journal of Medicine, vol. 367, no. 4, pp. 319-328 (2012)
Abstract: BACKGROUND: The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested. METHODS: We randomly assigned 12,537 people (mean age, 63.5 years) with cardiovascular risk factors plus impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes to receive insulin glargine (with a target fasting blood glucose level of ≤95 mg per deciliter [5.3 mmol per liter]) or standard care and to receive n-3 fatty acids or placebo with the use of a 2-by-2 factorial design. The results of the comparison between insulin glargine and standard care are reported here. The coprimary outcomes were nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes and these events plus revascularization or hospitalization for heart failure. Microvascular outcomes, incident diabetes, hypoglycemia, weight, and cancers were also compared between groups. RESULTS: The median follow-up was 6.2 years (interquartile range, 5.8 to 6.7). Rates of incident cardiovascular outcomes were similar in the insulin-glargine and standard-care groups: 2.94 and 2.85 per 100 person-years, respectively, for the first coprimary outcome (hazard ratio, 1.02; 95% confidence interval [CI], 0.94 to 1.11; P=0.63) and 5.52 and 5.28 per 100 person-years, respectively, for the second coprimary outcome (hazard ratio, 1.04; 95% CI, 0.97 to 1.11; P=0.27). New diabetes was diagnosed approximately 3 months after therapy was stopped among 30% versus 35% of 1456 participants without baseline diabetes (odds ratio, 0.80; 95% CI, 0.64 to 1.00; P=0.05). Rates of severe hypoglycemia were 1.00 versus 0.31 per 100 person-years. Median weight increased by 1.6 kg in the insulin-glargine group and fell by 0.5 kg in the standard-care group. There was no significant difference in cancers (hazard ratio, 1.00; 95% CI, 0.88 to 1.13; P=0.97). CONCLUSIONS: When used to target normal fasting plasma glucose levels for more than 6 years, insulin glargine had a neutral effect on cardiovascular outcomes and cancers. Although it reduced new-onset diabetes, insulin glargine also increased hypoglycemia and modestly increased weight. (Funded by Sanofi; ORIGIN ClinicalTrials.gov number, NCT00069784.).
Keyword: Aged; Blood Glucose/analysis; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/etiology; Cholesterol/blood; Combination; Diabetes Mellitus; Double-Blind Method; Drug Therapy; Fasting; Fatty Acids; Female; Follow-Up Studies; Glucose Intolerance/complications; Glucose Intolerance/drug therapy; Hospitalization; Humans; Hypoglycemia/chemically induced; Hypoglycemic Agents/adverse effects; Hypoglycemic Agents/therapeutic use; Incidence; Insulin; Intention to Treat Analysis; Long-Acting/adverse effects; Long-Acting/therapeutic use; Male; Middle Aged; Omega-3/therapeutic use; Proportional Hazards Models; Triglycerides/blood; Type 2/complications; Type 2/drug therapy
URL: https://doi.org/10.1056/NEJMoa1203858
https://serval.unil.ch/notice/serval:BIB_24F963809D9F
BASE
Hide details
18
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
In: New England Journal of Medicine, vol. 367, no. 4, pp. 309-318 (2012)
BASE
Show details
19
Noise Control - Numerical Analysis of Parallel Perforated Single-Inlet and Double-Outlet Mufflers Using the Transfer Function
In: Acta acustica united with Acustica. - Stuttgart : Hirzel 96 (2010) 3, 445-451
OLC Linguistik
Show details
20
The pragmatics of corrections in first language acquisition: a relevance theoretic approach
Wang, C.. - : VDM Publishing House, 2009
BASE
Show details

Page: 1 2

Catalogues
0
0
3
0
0
0
0
Bibliographies
0
0
0
0
0
0
0
0
0
Linked Open Data catalogues
0
Online resources
0
0
0
0
Open access documents
23
0
0
0
0
© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern